Day: January 8, 2021

 COMMUNIQUEPar contrat en date du 25 octobre 2006 la société Crédit Agricole SA a confié à Kepler Cheuvreux la mise en œuvre d’un Contrat de Liquidité. Ce contrat a fait l’objet d’une mise à jour le 18 janvier 2019, notamment afin de prendre en compte les évolutions réglementaires résultant de l’adoption du Règlement (UEà 596/2014 sur les abus de marché (« MAR »).Ce Contrat de Liquidité, doté d’un montant initial de 50 Millions d’euros, renouvelable annuellement par tacite reconduction, a pour objet l’animation des actions de la société Crédit Agricole SA (Code ISIN : FR0000045072) sur le marché réglementé de NYSE Euronext Paris.Afin de réajuster l’enveloppe mise à disposition de ce contrat, il a été procédé, en date du 31 décembre 2020 à un remboursement de 411 790,09 € du compte de Liquidité.Pièce jointeCP Crédit Agricole...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESVANCOUVER, British Columbia, Jan. 08, 2021 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (TSXV: DGHI; OTCPK: HSSHF) announces that it has updated the terms of the fully subscribed non-brokered private placement as originally announced on January 5, 2021. The updated private placement of common shares (the “Shares”) will be sold at $0.81 per Share for gross proceeds of $283,400 (the “Offering”). The Company intends to close the Offering as soon as possible, subject to approval of the TSX Venture Exchange.Proceeds of the Offering will be used for the acquisition of miners and for general working capital purposes. The Shares issued...

 BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE DE CREDIT AGRICOLE S.A. Au titre du contrat confié par la société Crédit Agricole S.A. à Kepler Cheuvreux, à la date du 31 décembre 2020, les moyens suivants figuraient au compte de liquidité :– Titres :                   1 090 000– Espèces (€) :          38 751 199.88– Nombre de transactions exécutées sur le semestre à l’achat : 1 415– Nombre de transactions exécutées sur le semestre à la vente : 1 997– Volume échangé sur le semestre à l’achat en titres :                4 712 211– Volume échangé sur le semestre à l’achat en capitaux (€) :      38 720 278.88– Volume échangé sur le semestre à la vente en titres :              5 522 211– Volume échangé sur le semestre à la vente en capitaux (€) :    48 896 194.41Il est rappelé que...

PHOENIX, Jan. 08, 2021 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) today reported Mesa Airlines’ operating performance for December 2020.Mesa Airlines reported 25,933 block hours in December 2020, a 33.9 percent drop from December 2019 as a result of reduced schedules during the COVID-19 pandemic. The company also reported a controllable completion factor of 99.87 percent and 100 percent for its American and United operations, respectively.Operating statistics for December 2020 and fiscal year 2021 YTD are included in the table below.*Controllable Completion Factor excludes cancellations due to weather and air traffic control**Total Completion Factor includes all cancellationsAbout Mesa Air Group, Inc.Headquartered in Phoenix, Arizona, Mesa Air Group, Inc. is the holding company of Mesa Airlines, a regional air carrier...

HOUSTON, Jan. 08, 2021 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) is a leader in community-centered REITs that acquires, owns, manages, develops and redevelops high quality “e-commerce resistant” neighborhood, community and lifestyle retail centers, and premier shopping, dining and entertainment destinations. The Company announced that Jim Mastandrea, Chairman and Chief Executive Officer, and David Holeman, Chief Financial Officer will provide a virtual overview of the Company’s business to the investment community at the Capital One Securities Inaugural REIT Conference on Monday, January 11th, and Tuesday, January 12th, 2021.About Whitestone REITWhitestone is a community-centered shopping center REIT that acquires, owns, manages, develops and redevelops high-quality neighborhood...

NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Executive Chairman and Chief Executive Officer, will present at the 39th Annual J.P. Morgan Healthcare Conference, being held virtually. The presentation is scheduled to take place on Tuesday, January 12, 2021 at 2:00 PM ET.A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company’s website at http://ir.tgtherapeutics.com/events. A replay of the webcast will be available on TG’s website following the event.ABOUT TG THERAPEUTICS, INC.TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Currently,...

MONTREAL, Jan. 08, 2021 (GLOBE NEWSWIRE) — Vanstar Mining Resources (TSX.V – VSR) is pleased to announce the nomination of Mr. J.C. St-Amour as President and CEO of Vanstar effective Monday, January 11, 2021. Mr. St-Amour is succeeding Mr. Jonathan Hamel who held the interim role until this appointment.Mr. St-Amour has over 20 years of mining industry experience in executive leadership roles, corporate finance and mergers & acquisitions. He has a master’s degree in geology and is a Chartered Financial Analyst with strengths and expertise in capital markets, financial and investment analysis, asset valuation, and managing financing and M&A transactions in the natural resource sector. During his career, Mr. St-Amour has held various executive leadership roles at the management and Board of Directors level in junior...

MONTRÉAL, 08 janv. 2021 (GLOBE NEWSWIRE) — Resources Minières Vanstar Inc. a le plaisir d’annoncer la nomination de M. J.C. St-Amour à titre de président et chef de la direction de Vanstar à compter du lundi 11 janvier 2021. M. St-Amour succède à M. Jonathan Hamel qui a occupé le poste par intérim jusqu’à cette nomination.M. St-Amour possède plus de 20 ans d’expérience dans l’industrie minière dans des rôles de direction, en finance d’entreprise et en fusions et acquisitions. Il détient une maîtrise en géologie et est un analyste financier agréé (CFA) avec une expertise dans les marchés de capitaux, l’analyse financière et des investissements, l’évaluation des actifs et la gestion des opérations de financement et de fusion et acquisition dans le secteur des ressources naturelles. Au cours...

MIAMI, FL, Jan. 08, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the month of November 2020.• Consolidated gross sales across all locations during November 2020 totaled $3.4 million, representing a 6.3% year-over-year growth when compared with November 2019.• Prescriptions filled during November came in at approximately 42,600, which was roughly flat (down less than 1%) on a year-over-year basis.• 340B fees grew 94% in November on a year-over-year basis, to approximately $212,000.• The Company booked approximately $160,000 in revenues related to Rapid Results COVID-19 Virus Testing in November, up 72% on a month-over-month basis.“While this remains a...

SOUTH SAN FRANCISCO, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced it will be showcasing new transplant data at the upcoming 21st Annual American Society of Transplant Surgeons (ASTS) Digital Winter Symposium.CareDx is sponsoring two symposia with key clinical leaders within transplantation, the speakers covering their real-world experiences using AlloSure to optimize care for their transplant patients, and highlighting novel data on the clinical utility of AlloSure. Of note, Dr. Jason Wellen will share initial data from the ADMIRAL study on AlloSure surveillance outcomes, and Dr. Sander Florman will...